Skip to main content
. 2021 Jul 28;11(7):e045797. doi: 10.1136/bmjopen-2020-045797

Table 2.

Incidence of type 2 diabetes per 1000 person-years in patients with prostate cancer by ADT use

Number of patients Number of events Person years Incidence rate
All patients 27 580 1371 185 961.74 7.4
ADT non-users 14 502 570 94 866.21 6.0
ADT users 13 078 801 91 095.53 8.8
GnRH agonists users 12 064 759 87 683.91 9.0
Antiandrogen users 1014 42 3411.62 5.8

ADT, androgen deprivation therapy; GnRH, gonadotropin-releasing hormone.